Valencia, Feb 3 (EFE) .- The Ombudsman Trustee of the Region has urged the Department of Health to establish “as soon as” the “diagnosis and severity” of the two children who were hospitalized after being administered vaccine against human papillomavirus (HPV), in order “to offer the best treatment option.”
The Ombudsman, José Cholbi, addresses and trade complaints by families of two children, aged 14, admitted on 4 and 6 February 2009 at the Clinical Hospital of Valencia with headache and seizures and where they stayed for several months.
The Trustee also suggests a Health Ombudsman to assess, within their jurisdiction, “increase the actions of a researcher in order to be able to define the risks and benefits for women the administration of the HPV vaccine.”
In the complaint filed by the families, they claim that one girl is in a wheelchair and progressively losing vision in both eyes, and the other you can not give any medication, “it takes all the side effects, thereby concern in the event of any illness or accident that may occur. “
“It is a benchmark of the seriousness with which we face, disappointed and helpless when fight something without a diagnosis and without all the unconditional attention on these cases and many more that exist in Spain,” say the families of the two children.
In the letter to the Ombudsman referred to the Minister for Health, said that a group of experts convened by the Spanish Agency of Medicines concluded that there was “dropped” the “causal link between the administration of the second dose of vaccine against papilloma virus human and the appearance of symptoms. “
In addition, indicated that the risk-benefit of vaccines against Human Papilloma Virus “has not changed and remains favorable.”
The letter from the Ombudsman also notes that in October 2009 the Department of Health informed the Ombudsman that he was unaware Syndicate which was at that time the clinical condition of the two girls concerned.
In addition, reported that in the first year of vaccination against HPV, with data in late September, 20,106 had been administered the first dose of vaccine, with a coverage of 82.28% of adolescents, the second dose, 19 142 vaccines and 81.19% coverage, and the third were 16,991 vaccinations and a 72.07% coverage.
Regarding the possible cause-effect relationship between the administration of the second HPV vaccine and the clinical picture showed the girls, Cholbi says it does not belong to the Ombudsman to “enter into the analysis of scientific and technical issues, such as this case. “
“Our work is limited to monitoring the performance of the health authorities and the diligent fulfillment of their performance,” said Cholbi, who indicated that this issue “must be clarified within the judicial process.”
It also notes that it is “difficult” for the institution headed “determine the risks and benefits for women the HPV vaccine,” and therefore considers that the health authorities “should encourage research neutral, transparent and, above all, act in the public interest. “ EFE